Patent · US Active

STAT3 inhibitors

US11826315B2 · kind B2 · utility

1Cited by
10References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 18, 2019
Grant dateNov 28, 2023
Priority date
Expiry dateJul 29, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C311/29
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds as STAT3 inhibitors are described. A pharmaceutical composition comprising the same, methods of making the same, and a method for treating or preventing conditions such as cancer, chronic inflammation, and fibrosis using the same, are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.